Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 29 - Friday, August 02, 2024), and click each link to read and watch anything you may have missed.
1.) Bayer submits NDA for elinzanetant to treat vasomotor symptoms
Bayer has submitted a New Drug Application for elinzanetant, following positive results from the OASIS studies, showing significant safety and efficacy in treating moderate-to-severe vasomotor symptoms in menopausal women.
Click here for the full article.
2.) First hysterectomy using miniaturized MIRA Surgical System performed
Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Click here for the full article.
3.) Surge in self-managed abortions reported post-Dobbs decision
Following the Supreme Court's Dobbs decision, rates of self-managed abortions have risen significantly, especially among marginalized communities, highlighting growing barriers to accessing legal abortion care.
Click here for the full article.
4.) Gestational carrier pregnancies: Balancing outcomes and risks
A recent study highlights the improved outcomes yet elevated risks associated with gestational carrier pregnancies compared to general pregnancies.
Click here for the full article.
5.) Preeclampsia linked to increased vascular dementia risk
A recent study found that women with preeclampsia during pregnancy face a higher risk of developing vascular dementia, but additional data was needed for other forms of dementia.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More
